TY - JOUR
T1 - Optical coherence tomography
T2 - The intraoperative assessment of lymph nodes in breast cancer
AU - Nguyen, Freddy T.
AU - Zysk, Adam M.
AU - Chaney, Eric J.
AU - Adie, Steven G.
AU - Kotynek, Jan G.
AU - Oliphant, Uretz J.
AU - Bellafiore, Frank J.
AU - Rowland, Kendrith M.
AU - Johnson, Patricia A.
AU - Boppart, Stephen A.
N1 - Funding Information:
Freddy T. Nguyen received the B.S. degree in chemistry and the B.A. degree in mathe-matics from Rice University in 2002. Since 2003, he has been at the University of Illi-nois at Urbana-Champaign where he is an M.D.–Ph.D. candidate. He currently holds a predoctoral fellowship from the Department of Defense’s Congressionally Directed Medical Research Programs—Breast Cancer Program. He was a research engineer in the G.R. Harrison Spectroscopy Laboratory at the Massachusetts Institute of Technology from 2002 to 2003. He is a member of the American Medical Association, the American Association for the Advancement of Science, the American Association for Cancer Research, and the American Chemical Society. His research interests have broadly been in the development of spectroscopic and imaging techniques and their associated contrast agents for direct biomedical applications such as cancer and atherosclerosis.
Funding Information:
This study was supported by the National Institutes of Health NIBIB, R01 EB005221, Carle Foundational Hospital, and the Grainger Foundation. Stephen A. Boppart is the principal investigator on all of these grants and he also receives patent royalties from the Massachusetts Institute of Technology for technologies associated with OCT. Freddy T. Nguyen was supported by the U.S. Department of Defense grant BC073292. The authors acknowledge the technical contributions of Dr. Daniel Marks, the assistance with histological analysis by Dr. Marina Marjanovic, and the contributions of Ann Benefiel, Mary Collins, and Barbara Hall in the recruitment and consenting of patients. They also thank the physicians, staff, and administration at Carle Foundation Hospital and Carle Clinic Association for their assistance in this research. Additional information can be found at http:// biophotonics.illinois.edu.
PY - 2010/3
Y1 - 2010/3
N2 - During breast-conserving surgeries, axillary lymph nodes draining from the primary tumor site are removed for disease staging. Although a high number of lymph nodes are often resected during sentinel and lymph-node dissections, only a relatively small percentage of nodes are found to be metastatic, a fact that must be weighed against potential complications such as lymphedema.Without a real-time in vivo or in situ intraoperative imaging tool to provide a microscopic assessment of the nodes, postoperative paraffin section histopathological analysis currently remains the gold standard in assessing the status of lymph nodes. Optical coherence tomography (OCT), a high-resolution real-time microscopic optical-imaging technique previously used to image breast cancer tumor margins intraoperatively in humans and lymph-node microarchitecture in a rat animal model, is being presented for the intraoperative ex vivo imaging and assessment of axillary lymph nodes. OCT provides real-time microscopic images up to 2 mm beneath the tissue surface in axillary lymph nodes. Normal (13), reactive (1), and metastatic (3) lymph nodes from 17 human patients with breast cancer were imaged intraoperatively with OCT. These preliminary clinical studies have identified scattering changes in the cortex, relative to the capsule, which can be used to differentiate normal from reactive and metastatic nodes. These optical scattering changes are correlated with inflammatory and immunological changes observed in the follicles and germinal centers. These results suggest that intraoperative OCT has the potential to assess the real-time node status in situ, without having to physically resect and histologically process specimens to visualize microscopic features.
AB - During breast-conserving surgeries, axillary lymph nodes draining from the primary tumor site are removed for disease staging. Although a high number of lymph nodes are often resected during sentinel and lymph-node dissections, only a relatively small percentage of nodes are found to be metastatic, a fact that must be weighed against potential complications such as lymphedema.Without a real-time in vivo or in situ intraoperative imaging tool to provide a microscopic assessment of the nodes, postoperative paraffin section histopathological analysis currently remains the gold standard in assessing the status of lymph nodes. Optical coherence tomography (OCT), a high-resolution real-time microscopic optical-imaging technique previously used to image breast cancer tumor margins intraoperatively in humans and lymph-node microarchitecture in a rat animal model, is being presented for the intraoperative ex vivo imaging and assessment of axillary lymph nodes. OCT provides real-time microscopic images up to 2 mm beneath the tissue surface in axillary lymph nodes. Normal (13), reactive (1), and metastatic (3) lymph nodes from 17 human patients with breast cancer were imaged intraoperatively with OCT. These preliminary clinical studies have identified scattering changes in the cortex, relative to the capsule, which can be used to differentiate normal from reactive and metastatic nodes. These optical scattering changes are correlated with inflammatory and immunological changes observed in the follicles and germinal centers. These results suggest that intraoperative OCT has the potential to assess the real-time node status in situ, without having to physically resect and histologically process specimens to visualize microscopic features.
UR - http://www.scopus.com/inward/record.url?scp=77949905317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949905317&partnerID=8YFLogxK
U2 - 10.1109/MEMB.2009.935722
DO - 10.1109/MEMB.2009.935722
M3 - Article
C2 - 20659842
AN - SCOPUS:77949905317
SN - 2154-2287
VL - 29
SP - 63
EP - 70
JO - IEEE Engineering in Medicine and Biology Magazine
JF - IEEE Engineering in Medicine and Biology Magazine
IS - 2
M1 - 5431924
ER -